STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation

BACKGROUND: Resistance to an immune checkpoint inhibitor (ICI) is a major obstacle in cancer immunotherapy. The causes of ICI resistance include major histocompatibility complex (MHC)/histocompatibility locus antigen (HLA) class I loss, neoantigen loss, and incomplete antigen presentation. Eliminati...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Takashi, Sato, Takanori, Endo, Rikito, Sasaki, Shun, Takahashi, Naomichi, Sato, Yusuke, Hyodo, Mamoru, Hayakawa, Yoshihiro, Harashima, Hideyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256839/
https://www.ncbi.nlm.nih.gov/pubmed/34215690
http://dx.doi.org/10.1136/jitc-2021-002852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256839/
https://www.ncbi.nlm.nih.gov/pubmed/34215690
http://dx.doi.org/10.1136/jitc-2021-002852

Ejemplares similares